Talphera, Inc. - ROE
TLPH
Price:
$1.09
Market Cap:
$22.36M
Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat. This anticoagulant is currently being assessed under an investigational device exemption for its application in extracorporeal circuits. The company's development pipeline also features LTX-608, a potential anti-inflammatory and antiviral agent being explored for the treatment of numerous conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-02-11
Stock Exchange
NASDAQ
Ticker
TLPH
PE Ratio
[-3.89]
ROE
[-92.98%]
Current Ratio
[5.30]
Dividend Yield
[0%]
Enterprise Value
[18.54M]
Dividend History
The ROE as of June 2026 (TTM) for Talphera, Inc. (TLPH) is -92.98%
According to Talphera, Inc.’s latest financial reports and current stock price. The company's current ROE is -92.98%. This represents a change of 232.79% compared to the average of -27.94% of the last 4 quarters.
Talphera, Inc. (TLPH) Historical ROE (quarterly & annually)
How has TLPH ROE performed in the past?
The mean historical ROE of Talphera, Inc. over the last ten years is -4.21%. The current -92.98% ROE has changed 2.11% with respect to the historical average. Over the past ten years (40 quarters), TLPH's ROE was at its highest in in the June 2022 quarter at 213.21%. The ROE was at its lowest in in the September 2016 quarter at -348.47%.
Average
-4.21%
Median
85.11%
Minimum
-1108.61%
Maximum
808.64%
Talphera, Inc. (TLPH) ROE by Quarter and Year
Discovering the peaks and valleys of Talphera, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 99.31%
Maximum Annual ROE = 808.64%
Minimum Annual Increase = -1197.44%
Minimum Annual ROE = -1108.61%
| Year | ROE | Change |
|---|---|---|
| 2025 | -83.89% | -48.39% |
| 2024 | -162.53% | 24.61% |
| 2023 | -130.43% | -166.92% |
| 2022 | 194.90% | 99.31% |
| 2021 | 97.79% | 35.01% |
| 2020 | 72.43% | -43.65% |
| 2019 | 128.54% | -111.60% |
| 2018 | -1108.61% | -885.78% |
| 2017 | 141.08% | -82.55% |
| 2016 | 808.64% | -1197.44% |
Talphera, Inc. (TLPH) Average ROE
How has TLPH ROE performed in the past?
The current ROE of Talphera, Inc. (TLPH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-125.61%
5-year avg
-16.83%
10-year avg
-4.21%
Talphera, Inc. (TLPH) ROE vs. Peers
How is TLPH’s ROE compared to its peers?
Talphera, Inc.’s ROE is greater than SCYNEXIS, Inc. (-57.16%), greater than Apimeds Pharmaceuticals US, Inc (-54.62%), greater than MIRA Pharmaceuticals, Inc. (-140.83%), greater than Nutriband Inc. (-112.60%), greater than iBio, Inc. (-53.86%), greater than Cosmos Health Inc. (-96.48%), less than Iterum Therapeutics plc (602.38%), less than P3 Health Partners Inc. (184.97%), greater than Intensity Therapeutics, Inc. (-136.82%), greater than Retractable Technologies, Inc. (-8.45%),
| Company | ROE | Market cap |
|---|---|---|
| -57.16% | $25.47M | |
| -54.62% | $1.37M | |
| -140.83% | $40.02M | |
| -112.60% | $35.25M | |
| -53.86% | $26.68M | |
| -96.48% | $13.22M | |
| 602.38% | $1.60M | |
| 184.97% | $35.41M | |
| -136.82% | $7.39M | |
| -8.45% | $20.06M |
Build a custom stock screener for Talphera, Inc. (TLPH) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Talphera, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Talphera, Inc. (TLPH) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Talphera, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Talphera, Inc.'s ROE?
How is the ROE calculated for Talphera, Inc. (TLPH)?
What is the highest ROE for Talphera, Inc. (TLPH)?
What is the 3-year average ROE for Talphera, Inc. (TLPH)?
What is the 5-year average ROE for Talphera, Inc. (TLPH)?
How does the current ROE for Talphera, Inc. (TLPH) compare to its historical average?